Volitionrx Common Stock Total Equity from 2010 to 2025

VNRX Stock  USD 0.63  0.01  1.56%   
Volitionrx Common Stock Total Equity yearly trend continues to be fairly stable with very little volatility. Common Stock Total Equity is likely to outpace its year average in 2025. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
2004-09-30
Previous Quarter
63.1 K
Current Value
78.1 K
Quarterly Volatility
20.2 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Volitionrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Volitionrx's main balance sheet or income statement drivers, such as Interest Expense of 267.6 K, Other Operating Expenses of 44.4 M or Total Operating Expenses of 44.4 M, as well as many indicators such as Price To Sales Ratio of 71.97, Dividend Yield of 0.0 or Days Sales Outstanding of 122. Volitionrx financial statements analysis is a perfect complement when working with Volitionrx Valuation or Volatility modules.
  
Check out the analysis of Volitionrx Correlation against competitors.
For more information on how to buy Volitionrx Stock please use our How to Invest in Volitionrx guide.

Latest Volitionrx's Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Volitionrx over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Volitionrx's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Volitionrx's overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

Volitionrx Common Stock Total Equity Regression Statistics

Arithmetic Mean34,533
Geometric Mean24,397
Coefficient Of Variation66.20
Mean Deviation19,859
Median35,340
Standard Deviation22,861
Sample Variance522.6M
Range68.6K
R-Value0.99
Mean Square Error13.1M
R-Squared0.98
Slope4,745
Total Sum of Squares7.8B

Volitionrx Common Stock Total Equity History

202569.9 K
202466.6 K
202157.9 K
202048.6 K
201941.1 K
201835.3 K
201726.5 K

About Volitionrx Financial Statements

Volitionrx investors use historical fundamental indicators, such as Volitionrx's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Volitionrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Total Equity66.6 K69.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Volitionrx Stock Analysis

When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.